1. Джобава Э.М., Степанян А.В., Артизанова Д.П. и др. Беременность групп риска. Современные подходы к терапии вагинальных дисбиозов. Гинекология. 2009; 1: 79–82.
2. Савичева А.М., Мартикайнен З.М., Селимян Н.К. Оценка действия препарата Тержинан на дрожжеподобные грибы рода Candida и вагинальные лактобациллы in vivo и in vitro. Практикующий врач. 2004; 3: 43–4.
3. Andrews WW, Goldenberg RL, Faye-Petersen O et al. TheAlabama Preterm Burth study: polymorhonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23-to 32-week preterm newborn infants. Am J Obstet Gynecol 2006; 195: 803.
4. Bradshaw CS, Tabrizi SN, Fairley CK et al. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 2006; 194: 828.
5. Fredricks DN, Fiedler TL, Marazzo JM. Molecular indentification of bacterial vaginosis associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899.
6. Human R, Fukushima M, Diamond L et al. Microbes on the human vaginal epithelium. Proc Nat Acad Sci 2005; 22: 7952.
7. Petersen EE, Magnani P. Efficacy and safety of Vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study. Eur J Obstet Gyn Reprod Biol 2004; 117: 70–5.
8. Polatti F, Rampino M, Magnani P, Mascarucci P. «Gynecological Endocrinology», Vaginal pH-lowering effect of locally applied vitamin C in subjects with high vaginal pH. April 2006; 22 (4): 230–4.
9. Strus M, Malinowska M, Heczko PB. In vitro antagonistic effect of lactobacillus on organisms associated with bacterial vaginosis J RReprod Med 2002; 47 (1): 41–6.
10. Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors assotiated with acquisition of, or persistent colonization by vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis 2001; 184 (11): 1431–6.
________________________________________________
1. Джобава Э.М., Степанян А.В., Артизанова Д.П. и др. Беременность групп риска. Современные подходы к терапии вагинальных дисбиозов. Гинекология. 2009; 1: 79–82.
2. Савичева А.М., Мартикайнен З.М., Селимян Н.К. Оценка действия препарата Тержинан на дрожжеподобные грибы рода Candida и вагинальные лактобациллы in vivo и in vitro. Практикующий врач. 2004; 3: 43–4.
3. Andrews WW, Goldenberg RL, Faye-Petersen O et al. TheAlabama Preterm Burth study: polymorhonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23-to 32-week preterm newborn infants. Am J Obstet Gynecol 2006; 195: 803.
4. Bradshaw CS, Tabrizi SN, Fairley CK et al. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 2006; 194: 828.
5. Fredricks DN, Fiedler TL, Marazzo JM. Molecular indentification of bacterial vaginosis associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899.
6. Human R, Fukushima M, Diamond L et al. Microbes on the human vaginal epithelium. Proc Nat Acad Sci 2005; 22: 7952.
7. Petersen EE, Magnani P. Efficacy and safety of Vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study. Eur J Obstet Gyn Reprod Biol 2004; 117: 70–5.
8. Polatti F, Rampino M, Magnani P, Mascarucci P. «Gynecological Endocrinology», Vaginal pH-lowering effect of locally applied vitamin C in subjects with high vaginal pH. April 2006; 22 (4): 230–4.
9. Strus M, Malinowska M, Heczko PB. In vitro antagonistic effect of lactobacillus on organisms associated with bacterial vaginosis J RReprod Med 2002; 47 (1): 41–6.
10. Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors assotiated with acquisition of, or persistent colonization by vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis 2001; 184 (11): 1431–6.
Авторы
В.Н.Прилепская, Г.Р.Байрамова, А.С.Анкирская
ФГУ «Научный центр акушерства, гинекологии и перинатологии им. В.И.Кулакова Росмедтехнологий»